Allergan, Inc. et al. vs. BTL Medical Technologies S.R.O. et al.
Explore the PTAB proceeding PGR2021-00015 filed by Allergan, Inc. et al. on 2020-12-14. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
PGR2021-00015
Filing Date
2020-12-14
Accorded Filing Date
2020-12-14
Institution Decision Date
2021-06-17
Last Modified Date
—
Proceeding Type
PGR
Termination Date
—
Trial Status
Institution Denied
Parties & Counsel
Petitioner
Allergan, Inc. et al.
Represented By
Insogna, Anthony et alPatent Owner / Respondent
Patent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 3700 - Mechanical Engineering & Manufacturing
Decisions Rendered
0 Total
Proceeding Status
Institution Denied
Administrative Patent Judges (APJ Panel)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 28912 | Robert Sterne | +1 202-772-8555 |
| 29021 | Jorge Goldstein | +1 202-371-2600 |
| 32831 | Tracy-Gene Durkin | +1 202-371-2600 |
| 33876 | Donald Featherstone | +1 202-772-8629 |
| 33997 | Michael Ray | +1 202-772-8569 |
| 34368 | Randy Lacasse | +1 202-772-8678 |
| 34395 | Robert Millonig | +1 202-371-2600 |
| 35239 | Michael Lee | +1 703-628-0233 |
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 21 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 10,709,895 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,124,187 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2017000103 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2017010620 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2017624418 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 11,266,850 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,937,358 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2018000110 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,596,386 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 9,974,519 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,549,109 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,569,094 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,493,293 B2 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,549,110 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 10,478,634 B2 | US Continuation / Sibling | View Official Patent → |
LUMENIS BE LTD. v. BTL Healthcare Technologies A.S. et al.
LUMENIS BE LTD. v. BTL Healthcare Technologies A.S. et al.
Lumenis Be Ltd. v. BTL Healthcare Technologies A.S. et al.
Lumenis Be Ltd. v. BTL Healthcare Technologies A.S. et al.
Lumenis Be Ltd. v. BTL Healthcare Technologies A.S. et al.
Lumenis Be Ltd. v. BTL Healthcare Technologies A.S. et al.
Allergan, Inc. et al. v. BTL Medical Technologies S.R.O. et al.
Allergan, Inc. et al. v. BTL Medical Technologies S.R.O. et al.